Complexa, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.complexarx.com
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2020-08-26
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT04053543
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Duke University, Durham, North Carolina, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
- First Posted Date
- 2018-02-28
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03449524
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸Mayo Clinic, Jacksonville, Florida, United States
🇺🇸Washington Hospital (Medstar), Washington, District of Columbia, United States
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT03422510
- Locations
- 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸Northwest Louisiana Nephrology, Shreveport, Louisiana, United States
🇺🇸St. Clair Nephrology Research, Roseville, Michigan, United States
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
- Conditions
- Interventions
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02547402
- Locations
- 🇺🇸
Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
- First Posted Date
- 2015-06-02
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT02460146
- Locations
- 🇺🇸
Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States
Oral CXA-10 Study in Healthy Volunteers
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02313064
- Locations
- 🇺🇸
Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States
Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02248051
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States
Study of CXA-10 in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02127190
- Locations
- 🇺🇸
Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States